Pfizer Inc (NYSE:PFE)
| 38.32 Delayed Data As of 6:30pm ET |  +0.03 / +0.08%Today’s Change | 33.97 Today|||52-Week Range 44.90 | -12.21% Year-to-Date |
Latest PFE News | Press Releases
| Better Buy: Pfizer vs. Bristol-Myers Squibb Dec 08 / MotleyFool.com - Paid Partner Content | Better Buy: Amgen vs. Pfizer Dec 04 / MotleyFool.com - Paid Partner Content |
| 3 Dividend Stocks You Can Safely Hold for Decades Dec 06 / MotleyFool.com - Paid Partner Content | 3 Top Growth Stocks to Buy in December Dec 03 / MotleyFool.com - Paid Partner Content |
| Why Sorrento Therapeutics Was Right to Reject Takeover Bids With A 245% Premium Dec 05 / MotleyFool.com - Paid Partner Content | Here's Why Lexicon Pharmaceuticals Is Tumbling Today Dec 02 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 38.29 |
| Today’s open | 38.10 |
| Day’s range | 38.10 - 38.38 |
| Volume | 14,971,279 |
| Average volume (3 months) | 21,169,846 |
| Market cap | $211.9B |
Data as of 6:30pm ET, 12/09/2019
Growth & Valuation
| Earnings growth (last year) | -46.78% |
| Earnings growth (this year) | -1.55% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +2.10% |
| P/E ratio | 13.4 |
| Price/Sales | 4.86 |
| Price/Book | 3.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.46 | +0.50% |
| MRKMerck | -0.13 | -0.15% |
| BMYBristol-Myers Squibb | +1.33 | +2.22% |
| ABBVAbbVie | -0.54 | -0.62% |
Data as of 6:30pm ET, 12/09/2019
Financials
| Next reporting date | January 28, 2020 |
| EPS forecast (this quarter) | $0.57 |
| Annual revenue (last year) | $53.6B |
| Annual profit (last year) | $11.2B |
| Net profit margin | 20.77% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
